Diasorin | DIA - Ebitda

Stock Price
64.54
Daily Change
0.76 1.19%
Monthly
-4.72%
Yearly
-32.73%
Q1 Forecast
62.02

Diasorin reported EUR87M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Amplifon EUR 107.33M 38.85M Sep/2025
Avanos Medical USD 10M 73.9M Sep/2025
Brookdale Senior Living USD 111.07M 1.58M Sep/2025
Cencora USD 1.16B 116.6M Sep/2025
Diasorin EUR 87M 10M Sep/2025
Encompass Health USD 335.6M 35.5M Dec/2025
Enovis USD 111.9M 17.1M Dec/2025
GE HealthCare Technologies USD 909M 35M Sep/2025
OPKO Health USD 75.53M 144.7M Sep/2025
Pediatrix Medical Group USD 65.84M 21.47M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025